Come up with a name for your new list and we'll add to it:
AFFiRiS raised a round of funding on April 29, 2014. Investors include
Seventh Framework Programme.
AFFiRiS develops tailor-made therapeutic peptide vaccines against chronic diseases. Currently, its clinical pipeline consists of 3 drug candidates against Parkinson's, MSA and Hypercholesterolemia. Fu…